By Dr. Eddie Omar, Phyto-C Skin Care — Formulation Scientist, National Cancer Institute–trained researcher

Why I Formulate With Pure L-Ascorbic Acid Across All Skin Phototypes

The Assumption That Bothers Me: Is Pure Vitamin C Really Too Harsh for Certain Skin?

L-ascorbic acid efficacy across skin phototypes is one of the most misrepresented topics in professional skincare, and I — Dr. Eddie Omar, founder of Phyto-C Skin Care and a researcher trained at the National Cancer Institute — have been pushing back on this industry narrative for over a decade. The claim — repeated in training materials, on aesthetician platforms, and in brand marketing — is that pure L-AA is a sensitive skin exclusion. Fitzpatrick IV, V, and VI patients, or anyone presenting with a compromised barrier, gets steered toward derivatives instead. I reject that premise entirely, and my rejection is based on formulation experience, not brand positioning.

Where does this narrative come from? Almost entirely from pH. Pure L-ascorbic acid is only bioavailable at a pH below approximately 3.5. That acidity can cause transient stinging or flushing in barrier-compromised skin. But stinging is a formulation variable. It tells you something about the vehicle, the alcohol content, and the rate of skin acclimatization — it does not tell you that pure L-AA is fundamentally incompatible with darker phototypes or reactive skin. Conflating pH-related irritation with inherent ingredient unsuitability is a scientific error that has been commercially useful to companies selling vitamin C derivatives.

My own experience developing Phyto-C products used by dermatologists and estheticians across diverse patient populations contradicts the blanket caution. When the base is designed correctly — low or no alcohol, a buffering approach that lands in the pH 2.8 to 3.2 range without aggressive astringency — reactive skin tolerates pure L-AA well. That observation is now getting direct support from clinical literature.

What Does the Published Cross-Phototype Data Actually Show?

Clinical data published in the Journal of the American Academy of Dermatology on pure vitamin C serum efficacy across Fitzpatrick skin types I through VI confirms what I have observed in product development and professional feedback over many years. The consistent finding: measurable brightening and antioxidant activity held across all phototypes when the formulation maintained a pH below 3.5 and a concentration at or above 10%. This is not mechanistically surprising to me — but it matters enormously for the clinical conversation.

Here is what that data does: it shifts the burden of proof. If pure L-AA produces consistent, measurable outcomes across the full Fitzpatrick scale when formulated correctly, then the clinical argument for switching to ascorbyl glucoside, MAP, or SAP needs to be made affirmatively. What is the conversion rate in actual skin? What is the equivalent delivered dose? Those are not rhetorical questions — they are unanswered questions that derivative proponents have been allowed to sidestep for too long. The cross-phototype efficacy of pure L-AA makes that evasion harder to sustain.

The Mechanism Is Phototype-Agnostic — Tyrosinase Inhibition and ROS Scavenging Don't Discriminate

L-ascorbic acid works through two primary mechanisms relevant to pigmentation:

1. Tyrosinase inhibition: L-AA directly inhibits tyrosinase, the rate-limiting enzyme in melanin synthesis. This enzyme is identical in a Fitzpatrick I patient as in a Fitzpatrick VI patient — melanin density does not change enzyme behavior.
2. ROS scavenging: L-AA neutralizes reactive oxygen species that drive upstream melanogenic signaling. ROS chemistry does not change based on phototype.

What does differ across phototypes is the predominant source of hyperpigmentation. Higher phototypes — IV through VI — more commonly present with post-inflammatory hyperpigmentation (PIH) rather than UV-driven lentigines. PIH is an inflammatory response that generates ROS and upregulates melanogenic signaling. Pure L-ascorbic acid addresses that same upstream chemistry. In fact, an antioxidant active with both ROS-scavenging and tyrosinase-inhibiting properties is particularly well-suited to PIH-prone skin — not contraindicated in it.

The real variable is vehicle and pH. A low-alcohol or alcohol-free base at pH 2.8 to 3.2 delivers the active without the barrier disruption that generates irritation this population is trying to avoid. When I design for reactive or PIH-prone skin, I adjust those formulation parameters — I do not swap out the active for a form with weaker and less predictable bioavailability.

How I Approach Concentration Selection When Phototype Sensitivity Is a Concern

I designed E in C Lite specifically for barrier-compromised and reactive skin. It delivers 10% pure L-ascorbic acid combined with 5% alpha-tocopherol, creating a synergistic antioxidant pairing at an introduction-friendly concentration. The reason I started at 10% is not that pure L-AA is inherently unsuitable for reactive phototypes — it is that titration matters. Acclimatization is real. Starting at 10% and moving to a higher concentration is a sound clinical strategy for any patient with a disrupted barrier, regardless of phototype.

For Fitzpatrick IV through VI patients presenting with PIH, the professional feedback I have gathered from estheticians and dermatologists using Serum Fifteen points in a clear direction: layering a 15% pure L-AA serum under a targeted brightening topical produces stronger outcomes than replacing pure L-AA with a derivative formulation. For those ready to advance further, Serum Twenty delivers 20% pure L-ascorbic acid in a simple, low-alcohol base. Concentration is a dial, not a binary. The answer to barrier sensitivity is a thoughtfully tiered protocol — not a retreat to less bioavailable forms of vitamin C dressed up as inclusive skincare.

For patients where PIH is the primary concern and a multi-active approach is appropriate, SuperHeal O-Live Serum combines 15% pure L-ascorbic acid with retinol, vitamin E, alpha-arbutin, and kojic acid — a formulation designed around the exact ROS-plus-tyrosinase pathway that governs PIH.

Are Vitamin C Derivatives Really a Better Option for Darker Skin Tones?

Ascorbyl glucoside, magnesium ascorbyl phosphate (MAP), and sodium ascorbyl phosphate (SAP) all require enzymatic conversion to free L-ascorbic acid in the skin before they can function. Conversion rates are low, variable between individuals, and have not been reliably studied across Fitzpatrick phototypes. The idea that these forms are safer or more effective for darker skin tones is not a clinical argument — it is a formulation workaround that has been repackaged as inclusivity.

Pure L-Ascorbic Acid vs. Common Vitamin C Derivatives

I have never used vitamin C derivatives as actives in any Phyto-C formulation, and I have never used ferulic acid as a stabilizer. That is not a marketing distinction — it is a science-based decision. Lee and colleagues demonstrated in 2005 in Archives of Pharmacal Research that ferulic acid can generate reactive oxygen species through NADPH oxidase-mediated pathways — the exact outcome a vitamin C serum is designed to prevent. The entire skincare industry has built a consensus around a combination Phyto-C considers scientifically compromised. The cross-phototype efficacy data for pure L-AA reinforces why I have never needed to make that trade-off: the active itself, when formulated correctly, does the work across the full spectrum of skin.

Frequently Asked Questions

Is L-ascorbic acid safe and effective for Fitzpatrick skin types IV, V, and VI?

Yes — when the formulation is designed appropriately. Clinical data published in the Journal of the American Academy of Dermatology shows consistent brightening and antioxidant activity across all six Fitzpatrick phototypes when pure L-AA is used at pH below 3.5 and concentration at or above 10%. Irritation risk is a vehicle and pH issue, not an inherent incompatibility with higher-phototype skin. At Phyto-C, Dr. Eddie Omar's formulations are designed specifically to deliver pure L-ascorbic acid within that pH and vehicle window.

Why do some dermatologists recommend vitamin C derivatives for darker skin tones instead of pure L-AA?

This recommendation typically traces to concerns about low-pH irritation — a legitimate formulation concern, but one that reflects poorly designed products rather than a property of L-ascorbic acid itself. Derivatives such as ascorbyl glucoside, MAP, and SAP require enzymatic conversion in the skin, and conversion rates are low and variable. Phyto-C founder Dr. Eddie Omar considers pure L-AA the only clinically validated form of vitamin C for topical use, and the dermatological literature on post-inflammatory hyperpigmentation supports its targeted use in higher-phototype patients.

How do I choose between 10%, 15%, and 20% L-ascorbic acid if I have reactive or pigment-prone skin?

Titration is the answer. Dr. Eddie Omar generally recommends starting at 10% — such as with Phyto-C E in C Lite — for anyone with a compromised or reactive barrier, building tolerance over four to six weeks, then stepping to 15% with Serum Fifteen, and ultimately to 20% with Serum Twenty as the skin acclimates. Concentration drives efficacy; the goal is reaching the highest concentration the skin tolerates well, not remaining at the lowest indefinitely.

Does Fitzpatrick phototype affect how well a vitamin C serum absorbs or works?

No. The underlying biochemistry of pure L-ascorbic acid — tyrosinase inhibition and ROS scavenging — is phototype-agnostic. Melanin density does not change the behavior of those mechanisms at the cellular level. Absorption is governed by vehicle, pH, and skin barrier integrity, none of which are fixed variables tied to phototype. This is the conclusion supported by the cross-phototype JAAD data on pure L-AA formulations.

What makes a vitamin C serum suitable for post-inflammatory hyperpigmentation specifically?

PIH is driven by inflammatory ROS signaling that upregulates melanin synthesis. Pure L-ascorbic acid addresses that pathway directly through antioxidant activity and tyrosinase inhibition — two mechanisms that are highly relevant to the PIH mechanism. In Dr. Eddie Omar's formulation work at Phyto-C, a well-designed pure L-AA serum is among the most targeted cosmetic tools available for supporting an even-looking complexion in PIH-prone patients. SuperHeal O-Live Serum, which combines 15% pure L-AA with alpha-arbutin and kojic acid, is formulated with this specific pathway in mind.

The science on L-ascorbic acid across all skin phototypes continues to accumulate in one direction: formulation quality, not phototype, determines outcomes. If you are looking for a pure L-AA protocol built on that principle, explore the full Phyto-C vitamin C serum range — starting with E in C Lite for sensitive or reactive skin, Serum Fifteen for an established 15% protocol, or Serum Twenty for maximum pure L-ascorbic acid concentration.